PROTECT YOUR DNA WITH QUANTUM TECHNOLOGY
Orgo-Life the new way to the future Advertising by AdpathwayResearchers at the Justus-Liebig-University Gießen have reported that preventive application of four key lung growth factors does not protect lung resident mesenchymal stem cells from the damaging effects of hyperoxia. Published in Molecular and Cellular Pediatrics, the study demonstrates that these cytokines fail to attenuate the growth inhibition, cell death, and phenotype disruption caused by high oxygen exposure in cells derived from preterm infants. The findings challenge the therapeutic potential of single growth factor interventions for preventing bronchopulmonary dysplasia, a chronic lung disease affecting premature babies.
The study focused on mesenchymal stem cells, which are critical for lung development and are diffusely scattered in the lung tissue. In preterm infants, these cells are particularly vulnerable to hyperoxia, a condition of elevated oxygen levels that is a major contributor to bronchopulmonary dysplasia. The researchers investigated whether applying insulin-like growth factor 1, fibroblast-like growth factor 10, hepatocyte growth factor, or platelet-derived growth factor AA could preserve the functionality of these stem cells when exposed to high oxygen concentrations.
The experimental design involved isolating mesenchymal stem cells from tracheal aspirates of preterm infants with a gestational age of less than 30 weeks. The study included four different cell cultures, with a mean gestational age of 24 weeks and 3 days and a mean birth weight of 786 grams. These cells were cultured in a laboratory setting to simulate the conditions experienced by preterm infants in neonatal intensive care units, where oxygen exposure is often necessary to support survival but can be toxic to developing lungs.
Before exposing the cells to hyperoxia at 40% or 80% oxygen levels for 72 hours, the researchers applied the growth factors either once or repetitively every 24 hours. The concentrations used were based on published literature, with IGF-1 at 100 ng/ml and the other factors at 10 ng/ml. This preventive approach was chosen to maximize the potential benefit of the intervention, as in clinical settings, oxygen exposure typically begins immediately after birth, leaving little time for delayed therapeutic intervention.
The results showed that hyperoxia significantly inhibited the proliferation of the mesenchymal stem cells and induced cell death. The growth inhibition was more pronounced at 80% oxygen than at 40%, and cell death increased from less than 10% at 40% oxygen to 40% at 80% oxygen. Despite the preventive application of the growth factors, there was no measurable benefit on the count of living cells or a reduction in cell death induction. The one-time and repetitive applications of the cytokines did not alter the outcome, indicating that the direct toxic effects of hyperoxia on the stem cells are robust.
Furthermore, the study examined the expression of marker proteins, specifically platelet-derived growth factor receptor alpha and alpha-smooth muscle actin, which are critical for stem cell functionality. Hyperoxia led to a downregulation of these proteins, a hallmark of phenotype disruption in bronchopulmonary dysplasia. The preventive treatment with the growth factors did not preserve the levels of these proteins, suggesting that the cytokines could not counteract the molecular changes induced by high oxygen exposure. This lack of protection was consistent across both the 40% and 80% oxygen conditions.
The researchers also tested a combinatorial pretreatment with fibroblast-like growth factor 10 and platelet-derived growth factor AA to see if a synergistic effect could be achieved. However, this combination also failed to reduce the growth inhibition, cell death, or the downregulation of marker proteins. The results were uniform, with no trend towards a benefit observed for any of the four candidate cytokines, either individually or in combination. This suggests that the magnitude of the injury caused by hyperoxia is too severe to be mitigated by single or dual growth factor supplementation in this specific cell population.
The study acknowledges several limitations, including the small sample size of four different cell cultures and the simplified experimental setting that isolated the effects of hyperoxia from other factors such as mechanical ventilation and inflammation. The researchers noted that in vivo, the lung environment is more complex, involving multiple cell types and immune responses that were not accounted for in this in vitro model. Additionally, the cells were obtained from infants who had already been exposed to pro-inflammatory stimuli, which might have influenced their baseline responsiveness to the growth factors.
Despite these limitations, the findings provide valuable insights into the pathogenesis of bronchopulmonary dysplasia and the limitations of current therapeutic strategies. The study suggests that focusing on the functionality of mesenchymal stem cells is crucial when evaluating the therapeutic potential of lung growth promoting factors. The results imply that future research should consider the combination of multiple growth factors or alternative approaches, such as allogeneic mesenchymal stem cell application, which might offer a broader range of beneficial effects.
The authors emphasize that the data should encourage lung researchers to consider the direct effects of hyperoxia on stem cells when designing interventions for preterm infants. The study highlights the need for a more comprehensive understanding of the complex interactions between growth factors, oxygen exposure, and stem cell functionality in the developing lung. By identifying the lack of efficacy of these specific cytokines, the research helps to refine the search for effective treatments that can prevent the long-term respiratory complications associated with bronchopulmonary dysplasia.
To establish the human cell cultures, the investigators isolated lung resident mesenchymal stem cells from the tracheal aspirates of four preterm infants born before 30 weeks of gestation. Across the cohort, the infants had a mean gestational age of 24 weeks and 3 days, with an interquartile range extending from 23 weeks and 2 days to 27 weeks and 5 days. Their birth weights averaged 786 grams, with an interquartile range between 551 and 1147 grams, and the collective exhibited an approximately equal balance between male and female infants across various clinical stages of bronchopulmonary dysplasia. Tracheal aspirate samples were centrifuged at 2000 g for five minutes, and the resulting pellets were initially cultured on 96-well plates using MesenCult medium supplemented with 20 percent fetal calf serum, 10 millimolar HEPES buffer solution, and antibiotics comprising penicillin, streptomycin, and gentamycin. For ongoing expansion, the cells were transitioned into culture flasks in Dulbecco’s Modified Eagle Medium containing 10 percent fetal calf serum and routinely passaged upon reaching visual confluency exceeding 75 percent. Flow cytometry profiling confirmed culture purity above 95 percent, as demonstrated by uniform expression of the surface markers CD73 and CD90 alongside an absence of the leukocyte marker CD45.
For the subsequent experimental assays, the researchers plated 100,000 cells per well for flow cytometric evaluations and 200,000 cells per well for immunoblot analyses. Exposure conditions were sustained within dedicated chambers fitted with Greisinger electronic GOX 100 oxygen sensors, which maintained oxygen gas concentrations within an allowable variation of plus or minus 5 percent. Cell proliferation was quantified using a cell expansion index calculated from living cell counts derived from flow cytometry before and after exposure. To achieve accurate cell counts, 5,000 reference counting beads were incorporated into each sample. Flow cytometric assessment of cell death was performed using Annexin V conjugated to phycoerythrin alongside SYTOX Blue double staining after incubation on ice in binding buffer, measuring cell death as the ratio of dead cells to all single cells analyzed.
Western blot procedures evaluated how oxygen and growth factor treatments regulated intracellular marker proteins. Cell lysates prepared using RIPA buffer were quantified for protein content with the Pierce BCA Protein Assay Kit via Nanodrop technology. Protein extracts were denatured with Laemmli buffer containing 2-mercaptoethanol at 95 degrees Celsius for five minutes, separated on 10 percent SDS polyacrylamide gels, and transferred to nitrocellulose membranes with 0.2-micrometer pore dimensions. Membranes were blocked with 5 percent dry milk in Tris-buffered saline containing 2.5 percent Tween-20 for one hour at room temperature. Primary antibodies directed against alpha-smooth muscle actin, platelet-derived growth factor receptor alpha, and glyceraldehyde 3-phosphate dehydrogenase were incubated overnight at 4 degrees Celsius, followed by incubation with horseradish peroxidase-conjugated secondary antibodies. Densitometric band volumes were visualized using chemiluminescent reagents, captured with a ChemiDoc XRS imaging system, and normalized to the internal housekeeping control.
In establishing baseline exposure consequences, the team observed that exposure to 80 percent hyperoxia significantly decreased expression of alpha-smooth muscle actin, whereas platelet-derived growth factor receptor alpha was consistently downregulated under both 40 percent and 80 percent oxygen exposures across cultures. Despite the inability of recombinant insulin-like growth factor 1, fibroblast growth factor 10, hepatocyte growth factor, or platelet-derived growth factor AA to reverse these alterations during hyperoxia, control checks confirmed known baseline cytokine biological activities, including the characteristic upregulation of platelet-derived growth factor receptor alpha by fibroblast growth factor 10 and platelet-derived growth factor AA. The experimental outcomes showed comparable responses in cells isolated from male and female infants, as well as across donors experiencing milder or more severe pulmonary courses.
The researchers noted that because cytokine levels in the culture medium were not directly monitored over the 72-hour exposure duration, a rapid decline in cytokine stability under elevated oxygen cannot be definitively ruled out. In addition, isolating mesenchymal stem cells in monoculture prevents observing potential paracrine interactions with other essential lung compartments, such as the alveolar epithelium, vascular endothelium, or recruited inflammatory leukocytes, where growth factors might exert distinct protective functions.
Subject of Research: Efficacy of lung growth factors in preventing hyperoxia-induced damage to mesenchymal stem cells in preterm infants
Article Title: Preventive application of lung growth factors and lack of attenuation of phenotype disruption of lung resident MSC from preterm infants by hyperoxia
Article References: Holzfurtner, L., Behnke, J., Korte, P., Goetz, M. J., Petzinger, J., Windhorst, A. C., Shahzad, T., Rivetti, S., Dong, Y., Bellusci, S., & Ehrhardt, H. (2026). Preventive application of lung growth factors and lack of attenuation of phenotype disruption of lung resident MSC from preterm infants by hyperoxia. Molecular and Cellular Pediatrics, 13(1), Article 28. https://doi.org/10.1186/s40348-026-00241-4
Image Credits: AI Generated
DOI: 10.1186/s40348-026-00241-4
Keywords: bronchopulmonary dysplasia, mesenchymal stem cells, hyperoxia, preterm infants, lung growth factors, IGF-1, FGF-10, HGF, PDGF-AA, phenotype disruption, cell proliferation, cell death, PDGFRα, alpha-smooth muscle actin, neonatal intensive care, oxygen toxicity, in vitro study, tracheal aspirates, lung development, therapeutic intervention


3 hours ago
7




















English (US) ·
French (CA) ·